N-acetyl-D-galactosamine—the key sugar molecule leading a new era of targeted delivery 1811-31-0
Today, with the rapid development of medicinal chemistry and delivery systems, precise targeting has become the core pursuit of improving efficacy and reducing toxic and side effects. N-acetyl-D-galactosamine (GalNAc), as a naturally occurring amino sugar, is moving from basic biochemical research to the forefront of biomedical applications, becoming a "star molecule" and an indispensable building block for the development of liver-targeted therapies.
Today, with the rapid development of medicinal chemistry and delivery systems, precise targeting has become the core pursuit of improving efficacy and reducing toxic and side effects. N-acetyl-D-galactosamine (GalNAc), as a naturally occurring amino sugar, is moving from basic biochemical research to the forefront of biomedical applications, becoming a "star molecule" and an indispensable building block for the development of liver-targeted therapies.
Chemical Information
Chemical name: N-acetyl-D-galactosamine
Common name: GalNAc
Chemical formula: C₈H₁₅NO₆
Molecular weight: 221.21 g/mol
CAS number: 1811-31-0
Category: Monosaccharides
Structural features
GalNAc is an amino derivative of galactose. Its structure contains unique functional potential:
Key recognition skeleton: As the starting sugar group of a variety of complex sugar chains (such as mucin O-linked sugar chains), its structure is accurately recognized by specific receptor systems in organisms.
Acetylated amino group: The acetylated amino group at the C2 position is an important chemical basis for its stable existence and specific recognition. It also provides a site for subsequent chemical modifications.
Polyhydroxyl framework: Retains the polyhydroxyl structure of typical monosaccharides, giving it good water solubility and biocompatibility. It also provides flexible chemical linking points for connecting delivery vehicles or therapeutic molecules.
Main applications and advantages
Core ligand for liver-targeted delivery system
Specific recognition: GalNAc can be efficiently and specifically recognized by the asialoglycoprotein receptor (ASGPR) expressed in high abundance on the surface of liver parenchymal cells. ASGPR has extremely high affinity for ligands ending in GalNAc or galactose.
Achieve liver targeting: By using GalNAc as a target molecule and covalently connecting it to siRNA, ASO, small molecule drugs or nanocarriers, a "Trojan horse" can be constructed to guide the drug to accurately enter liver cells. This greatly improves drug enrichment in target organs while significantly reducing exposure and potential toxicity to other tissues.
Internalization and release: After ligand-receptor binding, it is efficiently internalized through the memory effect mediated by ASGPR, and the active pharmaceutical ingredients are released intracellularly to achieve efficient intracellular delivery. This technology has become the gold standard for today's RNAi therapies (such as the marketed GalNAc-siRNA conjugate drugs).
Cornerstone of glycochemistry and glycobiology research
Glycoconjugate synthesis: As a key starting material or intermediate, it is used to chemically or enzymatically synthesize complex glycopeptides, glycolipids and polysaccharides to facilitate the research and development of new carbohydrate drugs and vaccines.
Molecular probe development: It can be used to develop tool molecules for detecting ASGPR expression levels or studying sugar-receptor interactions, serving basic research and disease diagnosis.
Optimizing the performance of therapeutic drugs
Improve pharmacokinetics: Give the drug liver targeting, extend its action time at the target site, and improve the therapeutic index.
Modular design: GalNAc trivalent clustered ligand has become a modular, proven platform technology that can be quickly adapted to different nucleic acid sequences or drugs, accelerating the development of a new generation of liver-targeted therapies.
Conclusion
N-Acetyl-D-galactosamine is much more than a simple sugar molecule. It is an exquisite bridge connecting modern chemistry and life sciences, and a "smart key" to unlock precision liver medicine. From revolutionary RNAi therapies to cutting-edge targeted treatment strategies for liver diseases, to in-depth interpretation of the sugar code throughout life, GalNAc continues to demonstrate its indispensable value.
The above information is provided by the editor of KASONS and is for scientific research only.